GoldBamboo.com - Knowledge is strong medicine
  

Improving Chronic Disease Care with PatientSite - Article


  Not Signed In - Sign In / Register







[ Disclaimer: The information on GoldBamboo for any particular treatment, medicine, drug, or herbal product might be missing or incomplete, and should never be used as a single source of knowledge. GoldBamboo generally has links to authoritative sites displayed toward the bottom of each topic page under the heading "Resources". ]

Talking With Your Doctor

Communicating With Your Healthcare Provider




Clinical Trial: Improving Chronic Disease Care with PatientSite

This study is currently recruiting patients.
Verified by Robert Wood Johnson Foundation August 2005

Sponsored by: Robert Wood Johnson Foundation
Information provided by: Robert Wood Johnson Foundation
ClinicalTrials.gov Identifier: NCT00130416

Purpose

The overall goal of this randomized, controlled trial is to test whether educational interventions – directed toward empowering patients and delivered via the BIDMC’s secure patient Internet portal PatientSite – can improve the outcomes and satisfaction with care of adult primary care patients with 3 common conditions: chronic pain, depression, and progressive difficulty walking.
Condition Intervention
Depression
Pain
Mobility Difficulty
 Behavior: E-mail coaching to improve patient communication with doctor

MedlinePlus related topics:  Depression;   Pain

Study Type: Interventional
Study Design: Educational/Counseling/Training, Randomized, Single Blind, Placebo Control, Parallel Assignment, Efficacy Study

Further Study Details: 
Primary Outcomes: Resolution or Improvement in screened chronic condition; Improved communication with primary care doctor; Improved patient satisfaction; Improved physician satisfaction
Secondary Outcomes: favorable clinician assessment of the impact of the screening intervention on the efficiency and quality of care they deliver.
Expected Total Enrollment:  750

Study start: September 2004;  Expected completion: August 2006

PURPOSE OF PROTOCOL:

The overall goal of this randomized, controlled trial is to test whether educational interventions – directed toward empowering patients and delivered via the BIDMC’s secure patient Internet portal PatientSite – can improve outcomes and satisfaction with care of adult primary care patients with 3 common conditions: chronic pain, depression, and progressive difficulty walking.

Primary study outcomes include improvement among intervention patients in: (1) detection and treatment of the target conditions; (2) patient-reported signs and symptoms of pain, depression, and impaired lower extremity mobility; 3) patient-reported quality of life, patient-clinician communication, and satisfaction with care; and 4) health care utilization. The secondary outcome is physicians’ views that the intervention improved the efficiency and quality of care they deliver.

The specific aims of the project are: (1) to improve physicians’ detection and treatment of patient-reported pain, depression, and impaired walking among intervention patients compared to controls; (2) to reduce patient-reported symptoms of chronic pain, depression, and impaired walking among intervention patients compared to controls; (3) to improve patient-reported quality of life, patient-clinician communication, and satisfaction with care among intervention patients compared to controls; and (4) to improve physicians’ assessments of the efficiency of office visits and quality of care they provided for the 3 study conditions.

SIGNIFICANCE AND BACKGROUND FOR THE STUDY:

Chronic conditions affect 99 million Americans and limit the daily lives of 41 million (Institute for Health & Aging 1996). Moreover, these conditions are often unrecognized. Myriad reasons contribute to the under-diagnosis of chronic conditions, including problems with patient-clinician communication, providers’ lack of awareness of the prevalence of these conditions or how to screen for them, and abbreviated office visits (e.g., Beckman 1999). Many conditions are difficult to ascertain, such as depression and pain, without objective and readily apparent indicators of impairment. Some persons believe that mobility difficulties are an inevitable consequence of aging, and something that physicians can do little to help, and primary care physicians generally have little formal training in mobility assessments (Iezzoni 2003a). An accurate, timely, and inexpensive way to identify and address chronic conditions could potentially transform the care of patients, enhance their quality of life, improve clinicians’ work life, and mitigate the social cost of these conditions.

This project will test whether a secure patient Internet portal is a useful conduit for information that can improve patient care, by screening patients for certain conditions, communicating the results directly to the patient and their physician, empowering patients to address these condition with their physicians, facilitating clinicians’ actions, and activating patients to participate in their own care.

PATIENTSITE PatientSite is a secure, personalized messaging system serving BIDMC and affiliated sites. It allows patients to communicate confidentially with their physicians and the physicians’ staff via the Web. Patients are eligible to enroll in PatientSite if one of their physicians has agreed to use PatientSite. Data in PatientSite are encrypted and password protected. Patients register online, and receive passwords from administrators at their own practice site in order to confirm the patient’s identity. Patients and clinicians must use a confidential password to obtain access to the system. To alert PatientSite users to the presence of a message, PatientSite sends users a traditional email message that they have a PatientSite message, along with a link to the PatientSite Web portal.

DESCRIPTION OF RESEARCH PROTOCOL:

We are conducting a randomized, controlled trial of a PatientSite intervention designed to improve pain, depression, and impaired mobility among primary care patients, among other outcomes.

We are recruiting physicians who currently use PatientSite from among those practicing at BIDMC’s academic primary care practice and at 2 community practices affiliated with BIDMC. Patients of physicians who agree to participate are potentially eligible for the study. Two weeks before their next scheduled primary care office visit, we are sending these patients an e-mail invitation via PatientSite to participate in the study. The e-mail briefly describes the study (including the procedures for randomization) and links patients to a complete, electronic informed consent form as well as standard HIPAA disclosures.

Patients who electronically sign the informed consent, thereby agreeing to participate in the study, are sent a screening questionnaire asking about signs and symptoms of chronic pain, depression, and difficulty walking. Persons who screen positive for at least one of these three conditions are enrolled in the study and randomized to intervention and control groups.

Patients randomized to the intervention electronically receive an e-mail message containing additional information about ways to address the condition during their primary care visit within the upcoming two weeks. The message includes condition-specific suggestions about how to discuss the problem with their clinician, along with standard tips about communicating with doctors. It provides a confidential link to an “electronic advocate” – a clinical nurse “e-Coach” who coaches (advises) the patient online about how to address the problem with their physician in the upcoming appointment.

Patients randomized to the control group receive an e-mail containing links to federal government Web sites containing general health information unrelated to the target conditions.

We are surveying both intervention and control group subjects via PatientSite 1 week and 3 months after their index visit to find out about their visit and their satisfaction with care, their clinical outcomes relating to the target conditions, and use of additional health care services. At one week post-visit, we are specifically asking whether they discussed the condition with their clinician and whether the clinician did anything about it. We are further asking patients who did not address the symptom with their physician for the reason. Three months after the index visit, we re-administer the screening instruments used at baseline in order to ascertain change in the target conditions, quality of life, health communication, and satisfaction. We also review patients’ medical records to abstract demographic information (age, gender, race, ethnicity, primary language), administrative data (insurance type, utilization of health services), and clinical characteristics (from the index visit note written by the physician) to corroborate discussion and management of target conditions, and to assess medical care utilization.

We are surveying participating physicians at the conclusion of the study to obtain their perceptions about the impact of the intervention on their work including time burdens and quality of care. In addition, we are reviewing the electronic medical records to ascertain provider and utilization outcome information at the end of the study.

Eligibility

Ages Eligible for Study:  18 Years and above,  Genders Eligible for Study:  Both
Criteria

Inclusion Criteria:

primary care patients aged 18 and older, of participating physicians within 5 internal medicine practices in Boston registered users of patient-provider internet portal called PatientSite screened positive for depression, chronic pain, or lower extremity mobility difficulty

Exclusion Criteria:

current treatment for screened condition by medical or surgical specialist or other appropriate licensed health professional such as a physical therapist or mental health counselor

Location and Contact Information

Please refer to this study by ClinicalTrials.gov identifier  NCT00130416


Massachusetts
      Beth Israel Deaconess Medical Center, Boston,  Massachusetts,  02215,  United States; Recruiting
Lisa Iezzoni, MD  617-667-5871    liezzoni@bidmc.harvard.edu 
Suzanne Leveille, PhD  617-667-5313    sleveill@bidmc.harvard.edu 
Lisa I Iezzoni, MD, MSc,  Principal Investigator
Suzanne G Leveille, PhD,  Sub-Investigator
Roger Davis, ScD,  Sub-Investigator
John D Halamka, MD, MS,  Sub-Investigator
Russell S Phillips, MD,  Sub-Investigator

Study chairs or principal investigators

Lisa I Iezzoni, MD,  Principal Investigator,  Beth Israel Deaconess Medical Center   

More Information

Study ID Numbers:  51757
Last Updated:  August 12, 2005
Record first received:  August 12, 2005
ClinicalTrials.gov Identifier:  NCT00130416
Health Authority: United States: Institutional Review Board
ClinicalTrials.gov processed this record on 2005-08-23


Take control over your directory listings...INSTANTLY

Every day, thousands of users find businesses like yours in the GoldBamboo directory.

Limited Time Offer!!!

For only $50 a year, a savings of 50% off our standard rate:

  • Edit your listing (whenever you want!)
  • Link to your website
  • Choose which categories you are listed in
  • Describe your services

The process will take only a few minutes and consists of 3 easy steps:

1. Register     >     2. Edit Listings     >     3. Publish

Your Company
your street
yourtown, YS 12345
888-888-8888



No Thanks

Popular Treatments

Acne Treatment ADHD Treatment Allergy Treatment Alzheimer's Treatment
Anemia Treatment Arthritis Treatment Asthma Treatment Bipolar Disorder Treatment
Bird Flu Treatment Bladder Cancer Treatment Bladder Control Treatment Blood Pressure Treatment
Brain Tumor Treatment Breast Cancer Treatment Bronchitis Treatment Cancer Treatment
Cancer Alternative Treatment Cataract Treatment Cirrhosis Treatment Colitis Treatment
Colon Cancer Treatment Common Cold Treatment Conjunctivitis Treatment Constipation Treatment
Crohn's Disease Treatment Cystic Fibrosis Treatment Depression Treatment Dermatitis Treatment
Diabetes Treatment Edema Treatment Epilepsy Treatment Erectile Dysfunction Treatment
Fibromyalgia Treatment GERD Treatment Glaucoma Treatment Gout Treatment
Hay Fever Treatment Headache Treatment Heart Disease Treatment Hepatitis Treatment
High Blood Pressure Treatment High Cholesterol Treatment Hives Treatment Hypertension Treatment
Hypoglycemia Treatment IBS Treatment Impotence Treatment Indigestion Treatment
Infertility Treatment Influenza Treatment Insomnia Treatment Lactose Intolerance Treatment
Leukemia Treatment Lung Cancer Treatment Lyme Disease Treatment Macular Degeneration Treatment
Menopause Treatment Migraine Treatment Osteoarthritis Treatment Osteoporosis Treatment
Pancreatic Cancer Treatment PMS Treatment Pneumonia Treatment Prostate Diseases Treatment
Restless Leg Treatment Rheumatoid Arthritis Treatment Sepsis Treatment Sinusitis Treatment
Skin Cancer Treatment Sleep Apnea Treatment Snoring Treatment Stroke Treatment
Testicular Cancer Treatment
GoldBambooTM

Your Integrative Health and Wellness Resource for Talking With Your Doctor.

December 1, 2008



Page Updated: September 6, 2005
============== Advertisement ==============
Disclaimer: All material displayed on the GoldBamboo.com website is provided for educational purposes only. Consult a physician regarding the applicability of any information found on GoldBamboo.com to your symptoms or medical condition.

Home | About Us | Link To Us | Feedback | Disclaimer | Privacy Policy | Terms of Use | Health Forums

Copyright © 2004-2008 - Gold Bamboo LLC - All rights reserved.

HONcode accreditation seal.

We comply with the HONcode standard for health trust worthy information:
verify here.